![](/img/cover-not-exists.png)
TREATMENT WITH IMETELSTAT PROVIDES DURABLE TRANSFUSION INDEPENDENCE (TI) IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
Fenaux, P., Steensma, D. P., Van Eygen, K., Raza, A., Santini, V., Germing, U., Font, P., DÃez-Campelo, M., Thepot, S., Vellenga, E., Patnaik, M. M., Jang, J. H., Sherman, L., Sun, L., Varsos, H., RiVolume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000561628.96745.54
Date:
June, 2019
File:
PDF, 416 KB
2019